MetaCap

Agape ATP (ATPC) vs GeneDx (WGS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

GeneDx is the larger company by market cap ($1.99 billion vs $2.1 million), about 952.6 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

ATPC versus WGS key metrics
MetricATPCWGS
Share price$2.09$66.80
Market cap$2.09M$1.99B
1-day change+2.96%-2.52%
YTD return—-47.31%
1-year return—-43.25%
5-year return—-73.34%
Forward P/E—55.73
EPS (TTM)$-1.04$-3.63
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$73.50$170.87
52-week low$1.72$32.21
Distance from 52-week high-97.16%-60.91%
Analyst consensus—strong_buy
Avg. price target upside—+39.97%
Average volume829.95K728.47K
Shares outstanding1.00M29.82M
Employees—1,300
SectorHealth CareHealth Care
IndustryMedical/Nursing ServicesMedical/Nursing Services

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • GeneDx is about 952.6 times larger than Agape ATP by market value ($1.99B vs $2.09M).

About GeneDx

WGS stock →

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.

Health Care · Medical/Nursing Services · 1,300 employees

ATPC vs WGS FAQ

Which is bigger, Agape ATP or GeneDx?

GeneDx (WGS) is larger, with a market capitalization of $1.99B compared with $2.09M for Agape ATP (ATPC).

Are Agape ATP and GeneDx in the same industry?

Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.

More comparisons